Alerts
IPM Alliance launches at the World Health Assembly in Geneva
Global health leaders call for a shift from personalised medicine innovation to real-world implementation
Regulators Start Writing the Rules for AI-Driven Medicines
FDA Puts AI Inside the Evidence Machine
AI Diagnosis Has Entered the Access Debate
Lenacapavir Turns HIV Prevention Into an Access Stress Test
WHO’s AMR Plan Turns Access Into Preparedness
Geographic Atrophy Forces Europe to Define Meaningful Vision Benefit
Eye Health Moves From Charity Case to Investment Case
AI in Cardiology Moves From Promise to Policy Pressure
Europe’s Safe Hearts Plan Makes Prevention a Political Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.